This is not the most recent version of the article. View current version (13 OCT 2014)

Intervention Review

Acetylcholinesterase inhibitor treatment for myasthenia gravis

  1. Man Mohan Mehndiratta1,*,
  2. Sanjay Pandey1,
  3. Thierry Kuntzer2

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 16 FEB 2011

Assessed as up-to-date: 9 MAY 2011

DOI: 10.1002/14651858.CD006986.pub2


How to Cite

Mehndiratta MM, Pandey S, Kuntzer T. Acetylcholinesterase inhibitor treatment for myasthenia gravis. Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD006986. DOI: 10.1002/14651858.CD006986.pub2.

Author Information

  1. 1

    G.B. Pant Hospital, Department of Neurology, New Delhi, India

  2. 2

    CHU Vaudois and University of Lausanne, Nerve-Muscle Unit, Service of Neurology, Lausanne, Switzerland

*Man Mohan Mehndiratta, Department of Neurology, G.B. Pant Hospital, #502, Academic Block, New Delhi, 110002, India. mmehndi@hotmail.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 16 FEB 2011

SEARCH

This is not the most recent version of the article. View current version (13 OCT 2014)

  1. Current Version

    Acetylcholinesterase inhibitor treatment for myasthenia gravis

    Man Mohan Mehndiratta, Sanjay Pandey and Thierry Kuntzer

    Article first published online: 13 OCT 2014 | DOI: 10.1002/14651858.CD006986.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Acetylcholinesterase inhibitor treatment for myasthenia gravis

    Man Mohan Mehndiratta, Sanjay Pandey and Thierry Kuntzer

    Article first published online: 16 FEB 2011 | DOI: 10.1002/14651858.CD006986.pub2

  2. Version 1

    Anticholinesterase treatment for myasthenia gravis

    Man Mohan Mehndiratta, Thierry Kuntzer and Sanjay Pandey

    Article first published online: 23 JAN 2008 | DOI: 10.1002/14651858.CD006986